The Scottish Medicines Consortium has provided an update advising of the decision to adapt their normal ways of working.
Meetings have been suspended until further notice in order to release committee members and staff to support work aligned with COVID-19 resilience. A core team will continue to assess the new medicine submissions already in the system and work on urgent activities around COVID-19 as required.
The submissions that would have been evaluated during this period have been reviewed and the SMC is satisfied that other medicines are available for the relevant patient groups. At this time new submissions or resubmissions are not being accepted. Meetings will resume when allowed by the COVID-19 restrictions.
Action: Clinicians should be aware that, for the time being, the SMC will not be publishing monthly advice for medicines.
|« NICE Guidance - May 2020||CKS Updates - May 2020 »|